APO Research
Talk to an analyst

APO RESEARCH · REPORT

Adeno Associated Virus Production

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Adeno Associated Virus Production Market Analysis and Forecast 2026-2032

1 May 2026190 pages

Choose your research edition.

Industry ResearchAdeno Associated Virus Production Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Adeno Associated Virus Production Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Adeno Associated Virus Production Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adeno Associated Virus Production Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Adeno Associated Virus Production Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Adeno Associated Virus Production market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Adeno Associated Virus Production is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Adeno Associated Virus Production is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Adeno Associated Virus Production is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Adeno Associated Virus Production is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Adeno Associated Virus Production include Biovian, Charles River, Lonza, Merck Group, OriGene, Sigma-Aldrich, SIRION Biotech, Thermo Fisher Scientific and Vigene Biosciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Adeno Associated Virus Production, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Adeno Associated Virus Production, also provides the revenue of main regions and countries. Of the upcoming market potential for Adeno Associated Virus Production, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Adeno Associated Virus Production revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Adeno Associated Virus Production market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Adeno Associated Virus Production revenue, projected growth trends, production technology, application and end-user industry.

Adeno Associated Virus Production Segment by Company

Biovian

Charles River

Lonza

Merck Group

OriGene

Sigma-Aldrich

SIRION Biotech

Thermo Fisher Scientific

Vigene Biosciences

Yeasen Aav

Adeno Associated Virus Production Segment by Type

Large-Scale Production

Customized Production

Adeno Associated Virus Production Segment by Application

Vaccine Production

Gene Therapy

Others

Adeno Associated Virus Production Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adeno Associated Virus Production market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adeno Associated Virus Production and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adeno Associated Virus Production.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Adeno Associated Virus Production in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Adeno Associated Virus Production company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adeno Associated Virus Production revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Adeno Associated Virus Production Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Large-Scale Production Major Player Table 3. Customized Production Major Player Table 4. Global Adeno Associated Virus Production Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Vaccine Production Major Player Table 6. Gene Therapy Major Player Table 7. Others Major Player Table 8. Adeno Associated Virus Production Industry Trends Table 9. Adeno Associated Virus Production Industry Drivers Table 10. Adeno Associated Virus Production Industry Opportunities and Challenges Table 11. Adeno Associated Virus Production Industry Restraints Table 12. Global Adeno Associated Virus Production Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Adeno Associated Virus Production Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Adeno Associated Virus Production Market Share by Region (2021-2026) Table 15. Global Adeno Associated Virus Production Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Adeno Associated Virus Production Market Share by Region (2027-2032) Table 17. Global Adeno Associated Virus Production Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Adeno Associated Virus Production Revenue Market Share by Players (2021-2026) Table 19. Global Adeno Associated Virus Production Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Adeno Associated Virus Production Key Players Headquarters & Area Served Table 21. Global Adeno Associated Virus Production Players, Product Type & Application Table 22. Global Adeno Associated Virus Production Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Adeno Associated Virus Production by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Adeno Associated Virus Production Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Adeno Associated Virus Production Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Adeno Associated Virus Production Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Adeno Associated Virus Production Revenue Market Share by Type (2021-2026) Table 29. Global Adeno Associated Virus Production Revenue Market Share by Type (2027-2032) Table 30. Global Adeno Associated Virus Production Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Adeno Associated Virus Production Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Adeno Associated Virus Production Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Adeno Associated Virus Production Revenue Market Share by Application (2021-2026) Table 34. Global Adeno Associated Virus Production Revenue Market Share by Application (2027-2032) Table 35. Biovian Company Information Table 36. Biovian Business Overview Table 37. Biovian Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Biovian Adeno Associated Virus Production Product Portfolio Table 39. Biovian Recent Development Table 40. Charles River Company Information Table 41. Charles River Business Overview Table 42. Charles River Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Charles River Adeno Associated Virus Production Product Portfolio Table 44. Charles River Recent Development Table 45. Lonza Company Information Table 46. Lonza Business Overview Table 47. Lonza Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Lonza Adeno Associated Virus Production Product Portfolio Table 49. Lonza Recent Development Table 50. Merck Group Company Information Table 51. Merck Group Business Overview Table 52. Merck Group Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Merck Group Adeno Associated Virus Production Product Portfolio Table 54. Merck Group Recent Development Table 55. OriGene Company Information Table 56. OriGene Business Overview Table 57. OriGene Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. OriGene Adeno Associated Virus Production Product Portfolio Table 59. OriGene Recent Development Table 60. Sigma-Aldrich Company Information Table 61. Sigma-Aldrich Business Overview Table 62. Sigma-Aldrich Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sigma-Aldrich Adeno Associated Virus Production Product Portfolio Table 64. Sigma-Aldrich Recent Development Table 65. SIRION Biotech Company Information Table 66. SIRION Biotech Business Overview Table 67. SIRION Biotech Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. SIRION Biotech Adeno Associated Virus Production Product Portfolio Table 69. SIRION Biotech Recent Development Table 70. Thermo Fisher Scientific Company Information Table 71. Thermo Fisher Scientific Business Overview Table 72. Thermo Fisher Scientific Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Thermo Fisher Scientific Adeno Associated Virus Production Product Portfolio Table 74. Thermo Fisher Scientific Recent Development Table 75. Vigene Biosciences Company Information Table 76. Vigene Biosciences Business Overview Table 77. Vigene Biosciences Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Vigene Biosciences Adeno Associated Virus Production Product Portfolio Table 79. Vigene Biosciences Recent Development Table 80. Yeasen Aav Company Information Table 81. Yeasen Aav Business Overview Table 82. Yeasen Aav Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Yeasen Aav Adeno Associated Virus Production Product Portfolio Table 84. Yeasen Aav Recent Development Table 85. North America Adeno Associated Virus Production Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Adeno Associated Virus Production Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Adeno Associated Virus Production Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Adeno Associated Virus Production Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Adeno Associated Virus Production Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Adeno Associated Virus Production Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Adeno Associated Virus Production Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe Adeno Associated Virus Production Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe Adeno Associated Virus Production Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe Adeno Associated Virus Production Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Adeno Associated Virus Production Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Adeno Associated Virus Production Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Adeno Associated Virus Production Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe Adeno Associated Virus Production Revenue by Country (US$ Million) & (2027-2032) Table 99. China Adeno Associated Virus Production Revenue by Type (2021-2026) & (US$ Million) Table 100. China Adeno Associated Virus Production Revenue by Type (2027-2032) & (US$ Million) Table 101. China Adeno Associated Virus Production Revenue by Application (2021-2026) & (US$ Million) Table 102. China Adeno Associated Virus Production Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Adeno Associated Virus Production Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia Adeno Associated Virus Production Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia Adeno Associated Virus Production Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia Adeno Associated Virus Production Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Adeno Associated Virus Production Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Adeno Associated Virus Production Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia Adeno Associated Virus Production Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA Adeno Associated Virus Production Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA Adeno Associated Virus Production Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA Adeno Associated Virus Production Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA Adeno Associated Virus Production Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA Adeno Associated Virus Production Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA Adeno Associated Virus Production Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA Adeno Associated Virus Production Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Adeno Associated Virus Production Image Figure 2. Global Adeno Associated Virus Production Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adeno Associated Virus Production Market Size Share 2021 VS 2025 VS 2032 Figure 4. Large-Scale Production Image Figure 5. Customized Production Image Figure 6. Global Adeno Associated Virus Production Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Adeno Associated Virus Production Market Size Share 2021 VS 2025 VS 2032 Figure 8. Vaccine Production Image Figure 9. Gene Therapy Image Figure 10. Others Image Figure 11. Global Adeno Associated Virus Production Market Size (US$ Million) & (2021-2032) Figure 12. Global Adeno Associated Virus Production Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Adeno Associated Virus Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Adeno Associated Virus Production Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Adeno Associated Virus Production Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Adeno Associated Virus Production Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Adeno Associated Virus Production Revenue Market Share by Type (2021-2032) Figure 19. Global Adeno Associated Virus Production Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Adeno Associated Virus Production Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Adeno Associated Virus Production Revenue Market Share by Application (2021-2032) Figure 22. North America Adeno Associated Virus Production Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Adeno Associated Virus Production Revenue Share by Type (2021-2032) Figure 24. North America Adeno Associated Virus Production Revenue Share by Application (2021-2032) Figure 25. North America Adeno Associated Virus Production Revenue Share by Country (2021-2032) Figure 26. United States Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Adeno Associated Virus Production Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Adeno Associated Virus Production Revenue Share by Type (2021-2032) Figure 31. Europe Adeno Associated Virus Production Revenue Share by Application (2021-2032) Figure 32. Europe Adeno Associated Virus Production Revenue Share by Country (2021-2032) Figure 33. Germany Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Adeno Associated Virus Production Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Adeno Associated Virus Production Revenue Share by Type (2021-2032) Figure 43. China Adeno Associated Virus Production Revenue Share by Application (2021-2032) Figure 44. Asia Adeno Associated Virus Production Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Adeno Associated Virus Production Revenue Share by Type (2021-2032) Figure 46. Asia Adeno Associated Virus Production Revenue Share by Application (2021-2032) Figure 47. Asia Adeno Associated Virus Production Revenue Share by Region (2021-2032) Figure 48. Japan Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Adeno Associated Virus Production Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Adeno Associated Virus Production Revenue Share by Type (2021-2032) Figure 56. SAMEA Adeno Associated Virus Production Revenue Share by Application (2021-2032) Figure 57. SAMEA Adeno Associated Virus Production Revenue Share by Country (2021-2032) Figure 58. Brazil Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Adeno Associated Virus Production Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Large-Scale Production
  • Customized Production
Applications
  • Vaccine Production
  • Gene Therapy
  • Others
Companies covered
  • Biovian
  • Charles River
  • Lonza
  • Merck Group
  • OriGene
  • Sigma-Aldrich
  • SIRION Biotech
  • Thermo Fisher Scientific
  • Vigene Biosciences
  • Yeasen Aav

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Adeno Associated Virus Production Market by Type
  3. 1.2.1 Global Adeno Associated Virus Production Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Large-Scale Production
  5. 1.2.3 Customized Production
  6. 1.3 Adeno Associated Virus Production Market by Application
  7. 1.3.1 Global Adeno Associated Virus Production Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Vaccine Production
  9. 1.3.3 Gene Therapy
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Adeno Associated Virus Production Market Dynamics
  1. 2.1 Adeno Associated Virus Production Industry Trends
  2. 2.2 Adeno Associated Virus Production Industry Drivers
  3. 2.3 Adeno Associated Virus Production Industry Opportunities and Challenges
  4. 2.4 Adeno Associated Virus Production Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Adeno Associated Virus Production Market Perspective (2021-2032)
  2. 3.2 Global Adeno Associated Virus Production Growth Trends by Region
  3. 3.2.1 Global Adeno Associated Virus Production Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Adeno Associated Virus Production Market Size by Region (2021-2026)
  5. 3.2.3 Global Adeno Associated Virus Production Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Adeno Associated Virus Production Revenue by Players
  2. 4.1.1 Global Adeno Associated Virus Production Revenue by Players (2021-2026)
  3. 4.1.2 Global Adeno Associated Virus Production Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Adeno Associated Virus Production Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Adeno Associated Virus Production Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Adeno Associated Virus Production Key Players Headquarters & Area Served
  7. 4.4 Global Adeno Associated Virus Production Players, Product Type & Application
  8. 4.5 Global Adeno Associated Virus Production Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Adeno Associated Virus Production Market CR5 and HHI
  11. 4.6.3 2025 Adeno Associated Virus Production Tier 1, Tier 2, and Tier 3
5 Adeno Associated Virus Production Market Size by Type
  1. 5.1 Global Adeno Associated Virus Production Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Adeno Associated Virus Production Revenue by Type (2021-2032)
  3. 5.3 Global Adeno Associated Virus Production Revenue Market Share by Type (2021-2032)
6 Adeno Associated Virus Production Market Size by Application
  1. 6.1 Global Adeno Associated Virus Production Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Adeno Associated Virus Production Revenue by Application (2021-2032)
  3. 6.3 Global Adeno Associated Virus Production Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Biovian
  2. 7.1.1 Biovian Company Information
  3. 7.1.2 Biovian Business Overview
  4. 7.1.3 Biovian Adeno Associated Virus Production Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Biovian Adeno Associated Virus Production Product Portfolio
  6. 7.1.5 Biovian Recent Developments
  7. 7.2 Charles River
  8. 7.2.1 Charles River Company Information
  9. 7.2.2 Charles River Business Overview
  10. 7.2.3 Charles River Adeno Associated Virus Production Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Charles River Adeno Associated Virus Production Product Portfolio
  12. 7.2.5 Charles River Recent Developments
  13. 7.3 Lonza
  14. 7.3.1 Lonza Company Information
  15. 7.3.2 Lonza Business Overview
  16. 7.3.3 Lonza Adeno Associated Virus Production Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Lonza Adeno Associated Virus Production Product Portfolio
  18. 7.3.5 Lonza Recent Developments
  19. 7.4 Merck Group
  20. 7.4.1 Merck Group Company Information
  21. 7.4.2 Merck Group Business Overview
  22. 7.4.3 Merck Group Adeno Associated Virus Production Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Merck Group Adeno Associated Virus Production Product Portfolio
  24. 7.4.5 Merck Group Recent Developments
  25. 7.5 OriGene
  26. 7.5.1 OriGene Company Information
  27. 7.5.2 OriGene Business Overview
  28. 7.5.3 OriGene Adeno Associated Virus Production Revenue and Gross Margin (2021-2026)
  29. 7.5.4 OriGene Adeno Associated Virus Production Product Portfolio
  30. 7.5.5 OriGene Recent Developments
  31. 7.6 Sigma-Aldrich
  32. 7.6.1 Sigma-Aldrich Company Information
  33. 7.6.2 Sigma-Aldrich Business Overview
  34. 7.6.3 Sigma-Aldrich Adeno Associated Virus Production Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sigma-Aldrich Adeno Associated Virus Production Product Portfolio
  36. 7.6.5 Sigma-Aldrich Recent Developments
  37. 7.7 SIRION Biotech
  38. 7.7.1 SIRION Biotech Company Information
  39. 7.7.2 SIRION Biotech Business Overview
  40. 7.7.3 SIRION Biotech Adeno Associated Virus Production Revenue and Gross Margin (2021-2026)
  41. 7.7.4 SIRION Biotech Adeno Associated Virus Production Product Portfolio
  42. 7.7.5 SIRION Biotech Recent Developments
  43. 7.8 Thermo Fisher Scientific
  44. 7.8.1 Thermo Fisher Scientific Company Information
  45. 7.8.2 Thermo Fisher Scientific Business Overview
  46. 7.8.3 Thermo Fisher Scientific Adeno Associated Virus Production Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Thermo Fisher Scientific Adeno Associated Virus Production Product Portfolio
  48. 7.8.5 Thermo Fisher Scientific Recent Developments
  49. 7.9 Vigene Biosciences
  50. 7.9.1 Vigene Biosciences Company Information
  51. 7.9.2 Vigene Biosciences Business Overview
  52. 7.9.3 Vigene Biosciences Adeno Associated Virus Production Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Vigene Biosciences Adeno Associated Virus Production Product Portfolio
  54. 7.9.5 Vigene Biosciences Recent Developments
  55. 7.10 Yeasen Aav
  56. 7.10.1 Yeasen Aav Company Information
  57. 7.10.2 Yeasen Aav Business Overview
  58. 7.10.3 Yeasen Aav Adeno Associated Virus Production Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Yeasen Aav Adeno Associated Virus Production Product Portfolio
  60. 7.10.5 Yeasen Aav Recent Developments
8 North America
  1. 8.1 North America Adeno Associated Virus Production Revenue (2021-2032)
  2. 8.2 North America Adeno Associated Virus Production Revenue by Type (2021-2032)
  3. 8.2.1 North America Adeno Associated Virus Production Revenue by Type (2021-2026)
  4. 8.2.2 North America Adeno Associated Virus Production Revenue by Type (2027-2032)
  5. 8.3 North America Adeno Associated Virus Production Revenue Share by Type (2021-2032)
  6. 8.4 North America Adeno Associated Virus Production Revenue by Application (2021-2032)
  7. 8.4.1 North America Adeno Associated Virus Production Revenue by Application (2021-2026)
  8. 8.4.2 North America Adeno Associated Virus Production Revenue by Application (2027-2032)
  9. 8.5 North America Adeno Associated Virus Production Revenue Share by Application (2021-2032)
  10. 8.6 North America Adeno Associated Virus Production Revenue by Country
  11. 8.6.1 North America Adeno Associated Virus Production Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Adeno Associated Virus Production Revenue by Country (2021-2026)
  13. 8.6.3 North America Adeno Associated Virus Production Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Adeno Associated Virus Production Revenue (2021-2032)
  2. 9.2 Europe Adeno Associated Virus Production Revenue by Type (2021-2032)
  3. 9.2.1 Europe Adeno Associated Virus Production Revenue by Type (2021-2026)
  4. 9.2.2 Europe Adeno Associated Virus Production Revenue by Type (2027-2032)
  5. 9.3 Europe Adeno Associated Virus Production Revenue Share by Type (2021-2032)
  6. 9.4 Europe Adeno Associated Virus Production Revenue by Application (2021-2032)
  7. 9.4.1 Europe Adeno Associated Virus Production Revenue by Application (2021-2026)
  8. 9.4.2 Europe Adeno Associated Virus Production Revenue by Application (2027-2032)
  9. 9.5 Europe Adeno Associated Virus Production Revenue Share by Application (2021-2032)
  10. 9.6 Europe Adeno Associated Virus Production Revenue by Country
  11. 9.6.1 Europe Adeno Associated Virus Production Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Adeno Associated Virus Production Revenue by Country (2021-2026)
  13. 9.6.3 Europe Adeno Associated Virus Production Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Adeno Associated Virus Production Revenue (2021-2032)
  2. 10.2 China Adeno Associated Virus Production Revenue by Type (2021-2032)
  3. 10.2.1 China Adeno Associated Virus Production Revenue by Type (2021-2026)
  4. 10.2.2 China Adeno Associated Virus Production Revenue by Type (2027-2032)
  5. 10.3 China Adeno Associated Virus Production Revenue Share by Type (2021-2032)
  6. 10.4 China Adeno Associated Virus Production Revenue by Application (2021-2032)
  7. 10.4.1 China Adeno Associated Virus Production Revenue by Application (2021-2026)
  8. 10.4.2 China Adeno Associated Virus Production Revenue by Application (2027-2032)
  9. 10.5 China Adeno Associated Virus Production Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Adeno Associated Virus Production Revenue (2021-2032)
  2. 11.2 Asia Adeno Associated Virus Production Revenue by Type (2021-2032)
  3. 11.2.1 Asia Adeno Associated Virus Production Revenue by Type (2021-2026)
  4. 11.2.2 Asia Adeno Associated Virus Production Revenue by Type (2027-2032)
  5. 11.3 Asia Adeno Associated Virus Production Revenue Share by Type (2021-2032)
  6. 11.4 Asia Adeno Associated Virus Production Revenue by Application (2021-2032)
  7. 11.4.1 Asia Adeno Associated Virus Production Revenue by Application (2021-2026)
  8. 11.4.2 Asia Adeno Associated Virus Production Revenue by Application (2027-2032)
  9. 11.5 Asia Adeno Associated Virus Production Revenue Share by Application (2021-2032)
  10. 11.6 Asia Adeno Associated Virus Production Revenue by Country
  11. 11.6.1 Asia Adeno Associated Virus Production Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Adeno Associated Virus Production Revenue by Country (2021-2026)
  13. 11.6.3 Asia Adeno Associated Virus Production Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Adeno Associated Virus Production Revenue (2021-2032)
  2. 12.2 SAMEA Adeno Associated Virus Production Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Adeno Associated Virus Production Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Adeno Associated Virus Production Revenue by Type (2027-2032)
  5. 12.3 SAMEA Adeno Associated Virus Production Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Adeno Associated Virus Production Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Adeno Associated Virus Production Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Adeno Associated Virus Production Revenue by Application (2027-2032)
  9. 12.5 SAMEA Adeno Associated Virus Production Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Adeno Associated Virus Production Revenue by Country
  11. 12.6.1 SAMEA Adeno Associated Virus Production Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Adeno Associated Virus Production Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Adeno Associated Virus Production Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst